Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
198M
-
Shares change
-
+11.4M
-
Total reported value, excl. options
-
$526M
-
Value change
-
+$38.6M
-
Put/Call ratio
-
185.92
-
Number of buys
-
84
-
Number of sells
-
-58
-
Price
-
$2.66
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q4 2024
183 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q4 2024.
Nuvation Bio Inc. - Common Stock (NUVB) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 198M shares
of 339M outstanding shares and own 58.3% of the company stock.
Largest 10 shareholders include FMR LLC (45.3M shares), Decheng Capital LLC (26M shares), BlackRock, Inc. (18.5M shares), VANGUARD GROUP INC (15.7M shares), Omega Fund Management, LLC (13.1M shares), Octagon Capital Advisors LP (9.2M shares), Laurion Capital Management LP (6.49M shares), GEODE CAPITAL MANAGEMENT, LLC (4.95M shares), STATE STREET CORP (4.6M shares), and MPM BIOIMPACT LLC (4.16M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.